Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) and Connect Biopharma (NASDAQ:CNTB – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability. Volatility and Risk Galmed Pharmaceuticals has a […]
Maxim Group upgraded shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) from a hold rating to a buy rating in a report issued on Monday, MarketBeat reports. Separately, StockNews.com started coverage on shares of Galmed Pharmaceuticals in a research report on Wednesday, July 19th. They set a sell rating on the stock. Galmed Pharmaceuticals Stock […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD opened at $3.16 on Friday. The company has a market cap of $5.31 million, a PE ratio […]